Joseph C. Papa
2019 - Valeant Pharmaceuticals International
In 2019, Joseph C. Papa earned a total compensation of $17.1M as Chief Executive Officer at Valeant Pharmaceuticals International, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,240,000 |
|---|---|
| Option Awards | $1,999,998 |
| Salary | $1,500,000 |
| Stock Awards | $10,286,634 |
| Other | $115,014 |
| Total | $17,141,646 |
Papa received $10.3M in stock awards, accounting for 60% of the total pay in 2019.
Papa also received $3.2M in non-equity incentive plan, $2M in option awards, $1.5M in salary and $115K in other compensation.
Rankings
In 2019, Joseph C. Papa's compensation ranked 248th out of 13,971 executives tracked by ExecPay. In other words, Papa earned more than 98.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 248 out of 13,971 | 98th |
Division Manufacturing | 90 out of 5,701 | 98th |
Major group Chemicals And Allied Products | 24 out of 2,200 | 99th |
Industry group Drugs | 20 out of 1,886 | 99th |
Industry Pharmaceutical Preparations | 17 out of 1,398 | 99th |
Source: SEC filing on May 2, 2022.
Papa's colleagues
We found three more compensation records of executives who worked with Joseph C. Papa at Valeant Pharmaceuticals International in 2019.